Paper Review Records
全部论文审稿周期
14 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
179
天
Vectors Trgeting Hepatocyte: Reconstructive Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes
作者
Yan-Feng Yin; Chun-Tao Yan; Zheng Guan; Lu Yu; Chun-Mei Lei; Dongdong Wang; Jiayin Yang展开收起
作者单位
1. Biomedical Research Center, Affiliated Calmette Hospital of Kunming Medical University, the First Hospital of Kunming, Kunming, China; 2. Department of Pathology, Affiliated Calmette Hospital of Kunming Medical University, the First Hospital of Kunming, Kunming, China; 3. Department of Hepato-Biliary-Pancreatic Surgery, Affiliated Calmette Hospital of Kunming Medical University, the First Hospital of Kunming, Kunming, China; 4. Yunnan Institute of Microbiology, School of Life Science, Yunnan University, Kunming, China展开收起
36
天
Application of Fibronectin-Coated Microparticles for Isolation of Human iPSC-Derived MSCs
作者
Jae Hyeok Jang; In Sun Hwang; Ji Seob Kim; Sunjun Lee; Min Hee Moon; Bowon Kim; Seo Jeong Kim; Jongho Choi; Young Her; Soo-Hong Lee; Byung-Hyun Cha展开收起
作者单位
1. Department of Biomedical Systems Science, College of Biomedical Science, Kangwon National University, Chuncheon-si, Republic of Korea; 2. Department of Medical Biotechnology, Dongguk University, Goyang, Republic of Korea; 3. Oral Pathology, College of Dentistry, Kangwon National University, Gangneung-si, Republic of Korea; 4. Department of Dermatology, Kangwon National University Hospital, Kangwon National University School of Medicine, Chuncheon-si, Republic of Korea展开收起
198
天
160
天
Comparative Study of Mesenchymal Stem Cell Identity and Chondrogenic Differentiation Capacity of Human Nucleus Pulposus, Adipose and Bone Marrow Tissues Derived Mesenchymal Stem Cells
作者
Hataiwan Kunkanjanawan; Tanut Kunkanjanawan; Veerapol Khemarangsan; Siravich Suvithayasiri; Tawit Suriyo; Jutamaad Satayavivad; Warayos Trathitephun展开收起
作者单位
1. Medeze Research and Development Co., Ltd., Sam Phran, Thailand; 2. Medeze Group Pub. Co., Ltd., Sam Phran, Thailand; 3. Orthopedics Department, Chulabhorn Hospital, Lak Si, Thailand; 4. Laboratory of Pharmacology, Chulabhorn Research Institute (CRI), Khet Lak Si, Thailand; 5. Center of Excellence on Environmental Health and Toxicology (EHT), Ministry of Higher Education, Science, Research and Innovation (MHESI), OPS, Bangkok, Thailand展开收起
183
天
hsa_circ_0008758 Activates the MDM2/FOXO3a/PGK1 Pathway Through the miR-361-3p/SPIN1 Axis to Promote the Warburg Effect of Non-Small Cell Lung Cancer
作者
Lei Wei; Fei Xu; Lei Xiong; LeLe Wang; HaiRong Huang; Kang Wang; Jing Luo; Yi Shen; YanQing Wang; Feng Jiang展开收起
作者单位
1. Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing City, China; 2. Department of Cardiothoracic Surgery, Affiliated Jinling Hospital, Nanjing Medical University, Nanjing City, China; 3. Department of General Practice, Affiliated Jinling Hospital, Nanjing Medical University, Nanjing City, China展开收起
69
天
Non-Cytopathic Mammalian Orthoreovirus Infection Triggers Innate Immune Responses in Human Tonsil-Derived Mesenchymal Stem Cells: Implications for Cell Therapy Quality Control
作者
Jeong Eun Kim; Ji Yeong Noh; Kyeong Eun Lee; Young Il Lee; Juyun Park; Min Chan Kim; Da Hyeon Choi; Hye Ji Jung; Hee Sung Jung; Jung Won Park; Eun-Ok Lee; Van Thi Lo; Hye Kwon Kim; Yoon Shin Park展开收起
作者单位
1. Department of Biological Sciences and Biotechnology, School of Biological Sciences, College of Natural Sciences, Chungbuk National University, Cheongju, Republic of Korea; 2. Innovation Center Bio Team, LigaChem Biosciences, Inc., Daejeon, Republic of Korea; 3. Division of Emerging Infectious Diseases, Department of Laboratory Diagnosis and Analysis, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea; 4. Data Convergence Drug Research Center, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea; 5. Division of Next Generation Non-Clinical Research, Korea Institute of Toxicology, Daejeon, Republic of Korea; 6. RENEUM Co., Ltd., Cheongju, Republic of Korea展开收起
FAQ
Tissue Engineering and Regenerative Medicine审稿要多久?
截至2026-11-19,CrushSCI 收录了 Tissue Engineering and Regenerative Medicine 的 14 篇完整审稿记录。最快一篇从收稿到录用用了 36 天(Application of Fibronectin-Coated Microparticles for Isolation of Human iPSC-Derived MSCs,2026-04-20 收稿,2026-05-26 录用),最慢一篇用了 295 天;平均 135.4 天,中位数 115 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
